Previous close | 2.7150 |
Open | 2.6600 |
Bid | 2.6600 x 0 |
Ask | 2.8200 x 0 |
Day's range | 2.6600 - 2.6600 |
52-week range | 0.8670 - 5.5900 |
Volume | |
Avg. volume | 110 |
Market cap | 119.001M |
Beta (5Y monthly) | 2.01 |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Cardiff Oncology ( NASDAQ:CRDF ) First Quarter 2024 Results Key Financial Results Net loss: US$10.0m (loss narrowed by...
Cardiff Oncology ( NASDAQ:CRDF ) Full Year 2023 Results Key Financial Results Net loss: US$41.5m (loss widened by 7.1...
Strategic Clinical Advances Amidst Increased Operating Expenses